Key Findings

The study identifies and characterizes clinical variants of New Delhi Metallo-β-Lactamase (NDM), specifically NDM-4 (M154L) and NDM-12 (M154L, G222D), which show enhanced resistance to ampicillin under conditions of zinc(II) scarcity. These mutations improve catalytic efficiency and stability of the enzyme, contributing to increased antibiotic resistance.